Stockreport

Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program

Novan, Inc.  (NOVN) 
Last novan, inc. earnings: 11/12 04:23 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.novan.com
PDF – Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets initiating preclinical Invest [Read more]